Medicare Enrolled

Dr. Paul Sylvan, M.D.

Radiation Oncology · Rancho Mirage, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Mixed engagement
39000 BOB HOPE DR, Rancho Mirage, CA 92270
7607732038
In practice since 2006 (19 years)
NPI: 1205887403 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sylvan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sylvan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sylvan

Dr. Paul Sylvan is a radiation oncology specialist in Rancho Mirage, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Sylvan performed 11,091 Medicare services across 5,670 unique beneficiaries.

Between the years covered by Open Payments, Dr. Sylvan received a total of $59,682 from 10 pharmaceutical and/or device companies across 19 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in radiation oncology. Payments are distributed across multiple categories and often reflect legitimate professional engagement with the medical industry. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sylvan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 17% volume in CA $59,682 industry payments

Medicare Practice Summary

Medicare Utilization ↗
11,091
Medicare services
Top 17% in CA for radiation oncology
5,670
Unique beneficiaries
$18
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~584 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
MRI contrast dye injection (gadobutrol) 5,394 $0 $1
Screening mammography
An X-ray of the breast used to detect breast cancer in women who have no signs or symptoms of the disease.
1,711 $38 $302
3D screening mammography (tomosynthesis)
A screening imaging test of the breast using 3D technology to detect potential abnormalities.
1,710 $30 $127
Bone density scan (DEXA)
A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures.
808 $10 $50
Digital breast tomosynthesis (3D mammogram)
A specialized imaging test that creates three-dimensional pictures of the breast tissue to help detect abnormalities.
320 $23 $61
Diagnostic mammography of 1 breast
An X-ray examination of one breast to evaluate specific breast symptoms or abnormalities.
266 $30 $295
Diagnostic mammography of both breasts 206 $37 $374
Limited ultrasound of 1 breast
A focused ultrasound examination of a single breast to evaluate specific areas of concern.
164 $26 $78
Complete breast ultrasound, 1 breast
A complete ultrasound examination of one breast to visualize internal structures.
135 $36 $108
MRI scan of both breasts
A magnetic resonance imaging test that creates detailed pictures of both breasts to help evaluate breast tissue.
134 $147 $532
Blood creatinine level test
A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function.
64 $5 $16
Breast biopsy with ultrasound-guided localization device placement
This procedure involves taking a tissue sample from a breast growth and placing a marker device to locate it, guided by ultrasound imaging.
45 $111 $575
Breast biopsy with localization device using X-ray
A procedure to remove a sample of breast tissue for testing, using X-ray guidance to place a device that marks the location of the first growth.
42 $121 $441
X-ray of surgical specimen 40 $12 $22
MRI-guided breast biopsy with locating device
A biopsy of a breast growth is performed using MRI guidance, and a locating device is placed in the tissue.
15 $640 $2,242
Limited ultrasound of joint or extremity
A focused ultrasound exam of a specific joint or other structure in the arm or leg, excluding blood vessels.
14 $22 $32
Breast lesion localization using X-ray guidance
A procedure to place a locating device in the breast using X-ray imaging and needle guidance to mark the first identified growth.
12 $82 $560
Deep underarm lymph node biopsy or removal
A procedure to remove or sample deep lymph nodes located in the underarm area for examination.
11 $344 $1,136
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$59,682
Total received (2018-2024)
Avg $9,947/year across 6 years
Top 3% in CA for radiation oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
10
Companies
19
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Other
Charitable contributions, space rental, and other categories
$58,802 (98.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$880 (1.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$58,802
2023
$275
2022
$47
2021
$107
2019
$80
2018
$372

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Stryker Corporation
$58,802
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Stryker Corporation
$58,802
Bard Peripheral Vascular, Inc.
$365
Sirius Medical Systems
$205
HOLOGIC INC
$100
ABIOMED
$59
Hologic Sales and Service, LLC
$44
Lilly USA, LLC
$31
Delphinus Medical Technologies, Inc.
$27
West Therapeutics Development, LLC
$26
LEICA MICROSYSTEMS INC.
$23
Top 3 companies account for 99.5% of all-time payments
Associated products mentioned in payments ›
3DIMENSIONS · AIXPLORER ULTIMATE · BREVERA BREAST BIOPSY SYSTEM · ENCOR · ENCOR ENSPIRE · HORIZON A · Impella · Lazanda · Localizer · N/A · PINTUITION · ULTRACLIP · VERZENIO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Payments are distributed across multiple categories with no single dominant type. Total industry engagement is in the top 3% for radiation oncology in CA.

Looking for a radiation oncology specialist in Rancho Mirage?
Compare radiation oncologists in the Rancho Mirage area by procedure volume, costs, and industry payment transparency.
Browse radiation oncologists nearby

Geographic Context

Radiation oncologists within 10 mi
47
Per 100K population
1.9
County median income
$89,672
Nearest hospital
EISENHOWER MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Sylvan is a mixed practice specialist, with above-average Medicare volume (top 17% in CA), with mixed engagement industry engagement in the top 3% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Sylvan experienced with mri contrast dye injection (gadobutrol)?
Based on Medicare claims data, Dr. Sylvan performed 5,394 mri contrast dye injection (gadobutrol) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sylvan receive payments from pharmaceutical companies?
Yes. Dr. Sylvan received a total of $59,682 from 10 companies across 19 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sylvan's costs compare to other radiation oncologists in Rancho Mirage?
Dr. Sylvan's average Medicare payment per service is $18. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sylvan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →